Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
A "humanized" immune system rodent model is one in which human primary haematopoietic cells and tissues are implanted into an immunodeficient host that generate a functional human immune system. Humanized mice or rat model are commonly used as small animal models in biological and medical research for human therapeutics.
Market Analysis and Insights: Global Humanized Mouse and Rat Model Market
Due to the COVID-19 pandemic, the global Humanized Mouse and Rat Model market size is estimated to be worth US$ 119.3 million in 2022 and is forecast to a readjusted size of US$ 181.6 million by 2028 with a CAGR of 7.3% during the review period. Fully considering the economic change by this health crisis, Genetic accounting for % of the Humanized Mouse and Rat Model global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of RandD activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
Global Humanized Mouse and Rat Model Scope and Segment
Humanized Mouse and Rat Model market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Humanized Mouse and Rat Model market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Genetic
Cell-Based
Segment by Application
Pharmaceutical
Biotechnology Companies
CRO
By Company
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Humanized Mouse and Rat Model Market
Due to the COVID-19 pandemic, the global Humanized Mouse and Rat Model market size is estimated to be worth US$ 119.3 million in 2022 and is forecast to a readjusted size of US$ 181.6 million by 2028 with a CAGR of 7.3% during the review period. Fully considering the economic change by this health crisis, Genetic accounting for % of the Humanized Mouse and Rat Model global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
Growth in this market can primarily be attributed to factors such as the growing demand of personalized medicine, continuous support in the form of investments and grants from the government and private sectors, increasing number of RandD activities in pharmaceutical and biotechnology companies, and the increasing number of research activities involving humanized models. Increasing production of monoclonal antibodies and rising demand for humanized rat models are expected to provide a wide range of growth opportunities for players in the market.
Global Humanized Mouse and Rat Model Scope and Segment
Humanized Mouse and Rat Model market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Humanized Mouse and Rat Model market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Genetic
Cell-Based
Segment by Application
Pharmaceutical
Biotechnology Companies
CRO
By Company
The Jackson Laboratory (US)
Taconic Biosciences (US)
Horizon Discovery Group(UK)
genOway (France)
Charles River Laboratories (US)
Harbour Antibodies BV (China)
Hera BioLabs (US)
Vitalstar Biotechnology Co (China)
inGenious Targeting Laboratory (US)
AXENIS(France)
Crown Bioscience (US)
Transgenic (Japan)
Champions Oncology (US)
Horizon Discovery Group(UK)
Hera BioLabs (US)
Yecuris Corporation (US)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
